Losartan Impurity 35 | CAS 163077-64-3 - Request Quote
Losartan Impurity 35
| SZ CAT No: | SZ-L028075 |
| CAS No | 163077-64-3 |
| Mol.F. | C8H12ClN2O4S : Na |
| Mol.Wt. | 267.7 : 23.0 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 731762-39-3 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Losartan Impurity 35 is chemically Sodium (2-butyl-5-chloro-1H-imidazol-4-yl)(hydroxy)methanesulfonate. Losartan Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Losartan Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 163077-64-3
Purchase 163077-64-3
Order 163077-64-3
Enquire 163077-64-3
price of 163077-64-3
163077-64-3 Supplier
163077-64-3 Manufacturer
163077-64-3 Exporter
buy high quality Losartan Impurity 35
Purchase Losartan Impurity 35
Losartan Impurity 35 suppliers
Losartan Impurity 35 manufacturers
Losartan Impurity 35 price
Order Losartan Impurity 35
Enquire Losartan Impurity 35
Losartan Impurity 35 cost
Losartan Impurity 35 Supplier
Losartan Impurity 35 Distributor
Losartan Impurity 35 for Method Validation
Losartan Reference Standard
Losartan Impurity 35 for ANDA Filing
Losartan Impurity 35 for Forced Degradation Studies
Losartan Impurity 35 Identification Standards
Losartan Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.